UNSPSC 51184005: Glibornuride

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51184005

Definition

This classification denotes a hypoglycemic agent with the molecular formula C18H26N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VP83E7434R, chemically known as urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-, (1r,2r,3s,4s)- but more generally known as glibornuride, which bears US NIH Compound Identifier 33649.

Read the full definition

European Medicines Agency schedules Glibornuride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07917MIG WHO schedules glibornuride in its Anatomical Therapeutic Chemical (ATC) Classification. GLIBORNURIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule glibornuride under HS 29350090 and SITC 51580. As of Q4 2014, GLIBORNURIDE remains US FDA's Preferred Term for this commodity. SMILES: S(=O)(=O)(NC(=O)NC1C2C(C(C1O)(CC2)C)(C)C)C1CCC(CC1)C.

About UNSPSC 51184005

UNSPSC 51184005 Glibornuride, a Commodity code, covers generic pharmaceutical products supplied through cooperative purchasing agreements to state and local government facilities. State and local buyers under this code procure pharmaceutical manufacturers' products for distribution through authorized wholesalers to hospitals, clinics, and other public health facilities. The issuing bodies are primarily state health departments and multistate cooperative purchasing alliances, which aggregate demand across participating states and local jurisdictions to achieve volume pricing and standardized supply chains. The work involves manufacturers submitting detailed product specifications, pricing structures, and compliance certifications (including cGMP and Drug Supply Chain Security Act verification) to qualify for wholesale distribution agreements.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the most recent relevant opportunity on January 20, 2026 — an RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation serves participating state and local government facilities across Minnesota, Oregon, and other MMCAP member states, requiring awarded vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with availability by May 15, 2026 and contract effectiveness July 1, 2026. Evaluation emphasizes price competitiveness (75 percent weight), with secondary criteria including fixed pricing (10 percent), compliance with data format and EDI requirements (5 percent each), and administrative fee acceptance (5 percent). Vendors must maintain minimum insurance coverage of $5,000,000 commercial general liability, $2,000,000 network security and privacy liability, and $2,000,000 professional liability, and accept a 3 percent administrative fee on all contract purchases.

Quick answers

What is UNSPSC 51184005?

UNSPSC 51184005 is Glibornuride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51184005?

UNSPSC 51184005 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.

On GovTribe

See everything under UNSPSC 51184005

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code